Aortic Valve Treatment: from mechanical valves, following sutureless bioprosthesis, up to the transcatheter aortic valve implantation
Submission Deadline: 30 Apr 2022
Guest Editor
Prof. Giuseppe Santarpino is an Italian cardiac surgeon and academic, currently an Associate Professor at Magna Graecia University of Catanzaro and Paracelsus Medical University Nuremberg, and Chief Surgeon for GVM Care&Research, Cittá di Lecce Hospital, Italy. Trained in Naples and Nuremberg, he holds a PhD and dual master's degrees. And repeated "Researcher of the Year" & "Platinum Medal" recipient of PMU Nuremberg.
Interests: cardiopulmonary bypass; cardiovascular; cardiac surgery; cardiothoracic surgery; aortic valve; coronary artery bypass; heart failure; heart valve diseases; echocardiography; pacemakers
Special Issue Information
Dear Colleagues,
Waiting for the new guidelines for the valve treatment, the transcatheter aortic valve implantation is indicated up to the low risk patients. However, the heart team decision is the central point for the decision (surgical, minimally invasive, transcatheter). A Special Issue in this field is important to assist the debate in that treatment decisions and reflections.
The topic of interests in this issue include but are not limited to:
- mechanical aortic valve replacement;
- anticoagulant treatment;
- bio-aortic valve replacement;
- new device, new prostheses;
- stented, stentless, sutureless aortic valves;
- transcatheter aortic valves;
- comparing studies;
- follow up studies.
Manuscripts submitted to this Special Issue will be subjected to more stringent selection criteria to ensure the privileged position of accepted contributions. Those that fail to pass this selection will be considered for publication in RCM as regular contributions.
Prof. Dr. Giuseppe Santarpino
Guest Editor
Keywords
- Aortic valve replacement
- Heart team
- Transcatheter tratment
- New devices
Published Papers (3)
Biological Surgical Options in Young Patients for the Treatment of Severe Aortic Stenosis: Is the Jury Still Out? A Review
Rev. Cardiovasc. Med. 2022, 23(8), 274; https://doi.org/10.31083/j.rcm2308274
(This article belongs to the Special Issue Aortic Valve Treatment: from mechanical valves, following sutureless bioprosthesis, up to the transcatheter aortic valve implantation)
Bibliometric analysis of the inflammatory mechanism in aortic disease
Rev. Cardiovasc. Med. 2022, 23(2), 67; https://doi.org/10.31083/j.rcm2302067
(This article belongs to the Special Issue Aortic Valve Treatment: from mechanical valves, following sutureless bioprosthesis, up to the transcatheter aortic valve implantation)
Prediction of one- and two-year mortality after transcatheter aortic valve implantation: proposal of a fast sum-score system integrating a novel biomarker of cardiac extracellular matrix accumulation and fibrosis
Rev. Cardiovasc. Med. 2022, 23(2), 62; https://doi.org/10.31083/j.rcm2302062
(This article belongs to the Special Issue Aortic Valve Treatment: from mechanical valves, following sutureless bioprosthesis, up to the transcatheter aortic valve implantation)